Vanguard Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.94M Hold
839,306
– – ﹤0.01% 2824
2026
Q2
$9.02M Sell
839,306
-57,838
-6% -$472K ﹤0.01% 2879
2026
Q1
$5.52M Buy
+897,144
New +$6.93M ﹤0.01% 3020

Other funds holding FENC

Vanguard Capital Management's FENC Position: Q3 2026 in Review

Vanguard Capital Management held its Fennec Pharmaceuticals (FENC) position steady in Q3 2026 at 839,306 shares worth $8.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

Vanguard Capital Management first reported a position in FENC in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.02M in Q2 2026. 118 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • Vanguard Capital Management held 839,306 shares of Fennec Pharmaceuticals worth $8.94M as of Q3 2026.
  • Vanguard Capital Management left its Fennec Pharmaceuticals share count unchanged in Q3 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2824 holding.
  • Vanguard Capital Management first reported a position in Fennec Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Fennec Pharmaceuticals position peaked at $9.02M in Q2 2026.
  • 118 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.